Health Risks of Ionizing Radiation: - Clark University
Health Risks of Ionizing Radiation: - Clark University
Health Risks of Ionizing Radiation: - Clark University
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
myeloid leukemia) was significantly associated<br />
with dose as was mortality from multiple<br />
myeloma 9 . Wilkinson and Dreyer (1991) pooled<br />
the leukemia mortality results <strong>of</strong> seven worker<br />
studies. These authors found a significant risk<br />
among workers with doses <strong>of</strong> 0.01-0.05 Sv<br />
(Rate ratio 2.1, 90% CI 1.4-3.3).<br />
• Leukemia among nuclear weapons test<br />
veterans. Veterans who were involved with<br />
nuclear weapons testing were typically exposed<br />
to low doses <strong>of</strong> radiation 10 . Muirhead et al. (2003)<br />
did not detect any significant dose-response<br />
trends in a subgroup <strong>of</strong> UK veterans with dose<br />
information, but this is not surprising given the<br />
low numbers <strong>of</strong> cases 11 . UK veterans followed<br />
through 1983 showed increased mortality from<br />
leukemia (RR 3.45, 90% CI 1.50-8.37) and<br />
multiple myeloma (6 deaths among participants<br />
and zero deaths among controls); total cancer<br />
mortality was not different from controls (RR<br />
0.96, 90% CI 0.86-1.08). A purely low-dose<br />
cohort was studied by Caldwell et al. (1983);<br />
these were veterans <strong>of</strong> one test (Smoky, 1957)<br />
who had a mean dose <strong>of</strong> 0.005 Sv and a maximum<br />
dose <strong>of</strong> 0.1 Sv. Among these veterans there was<br />
a significant excess <strong>of</strong> leukemia, registered as<br />
either incidence or mortality (incidence RR<br />
2.5, 1.2-4.6), and total cancer mortality was not<br />
different from expected (incidence RR 0.95,<br />
0.78-1.14).<br />
• Medical exposures and leukemia. Studies <strong>of</strong><br />
diagnostic x-rays are <strong>of</strong> limited utility because<br />
they typically lack dose estimates. In one study<br />
that did estimate doses there was evidence <strong>of</strong><br />
a chronic myeloid leukemia risk at low doses<br />
(Preston-Martin et al. 1989). Out <strong>of</strong> 130 cases<br />
and 130 matched controls 80% had estimated<br />
cumulative bone marrow doses less than 0.02<br />
Gy. The maximum dose in this group would have<br />
Discussion 169<br />
been received by one patient who had 22 back<br />
x-rays; at 247-749 mrad per exam this would be<br />
a cumulative dose <strong>of</strong> 0.05-0.16 Gy. This group<br />
showed a significant dose-response relationship<br />
with an estimated ERR <strong>of</strong> 30/Gy. When analysis<br />
was restricted to the period within 6-10 years <strong>of</strong><br />
diagnosis the ERR estimate was 76/Gy and the<br />
OR for the 0.01-0.02 Gy exposure group was<br />
significantly positive (3.1, p